The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy.

PURPOSE The angiopoietin (Ang) system plays an important role in vascular stabilization and pathologic neovascularization. The hypothesis for the study was that, in addition to modulating endothelial cell behavior, the angiopoietin/Tie-2 system also regulates the pericyte apoptosis and/or the vessel maturation associated with diabetic retinopathy. METHODS Tie-2 expression in cultured retinal pericytes was analyzed by using ELISA, Western Blot analysis, and flow cytometry. CD13 (aminopeptidase N) expression in pericytes was determined by Western blot analysis and Ang effects verified with Tie-2 antisense treatment. Cell proliferation was monitored by crystal violet uptake, and pericyte migration was assessed in a scrape wound. Annexin V-FITC flow cytometry was used to quantify pericyte apoptosis. RESULTS Pericytes expressed a functionally active Tie-2 receptor upregulated by both Ang-1 and -2 (P < 0.05). In pericytes undergoing apoptosis induced by either TNF-alpha or high glucose Ang-1 increased survival (P < 0.05 for TNF-alpha; P < 0.01 for high glucose), whereas Ang-2 increased apoptosis. Ang-1 enhanced CD13 expression in a dose-dependent manner (P < 0.05) and stimulated pericyte migration in a synthetic matrix wound-healing assay that was associated with a change in F-actin organization. Addition of Tie-2 antisense confirmed that angiopoietins act through Tie-2. CONCLUSIONS These findings demonstrate that Tie-2 is functional in pericytes and may play an important role in the progression of diabetic retinopathy, by regulating pericyte loss and influencing the activation state and recruitment of pericytes.

[1]  S. Manna,et al.  Activation of nuclear transcription factor-κB in mouse brain induced by a simulated microgravity environment , 2005, In Vitro Cellular & Developmental Biology - Animal.

[2]  D. Dumont,et al.  Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization , 2006, Journal of Cell Science.

[3]  Dawn G. Smith,et al.  Glyoxalase I Is Critical for Human Retinal Capillary Pericyte Survival under Hyperglycemic Conditions* , 2006, Journal of Biological Chemistry.

[4]  W. Jiang,et al.  Pigment Epithelium-derived Factor Inhibits Angiogenesis via Regulated Intracellular Proteolysis of Vascular Endothelial Growth Factor Receptor 1* , 2006, Journal of Biological Chemistry.

[5]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[6]  P. Courtoy,et al.  Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. , 2006, European journal of cancer.

[7]  Alan W. Stitt,et al.  Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. , 2005, The American journal of pathology.

[8]  K. Plate,et al.  Tumorigenesis and Neoplastic Progression Angiopoietin-1 Promotes Tumor Angiogenesis in a Rat Glioma Model , 2004 .

[9]  T. Kita,et al.  Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. , 2004, Molecular vision.

[10]  M. Goldberg,et al.  Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis. , 2004, American journal of physiology. Renal physiology.

[11]  H. Hammes,et al.  Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. , 2004, Diabetes.

[12]  Dennis P. Han,et al.  Proliferative Diabetic Retinopathy , 2004, International ophthalmology clinics.

[13]  G. Martiny-Baron,et al.  Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood , 2004, Angiogenesis.

[14]  W. Stallcup,et al.  Early Contribution of Pericytes to Angiogenic Sprouting and Tube Formation , 2004, Angiogenesis.

[15]  W. Jiang,et al.  Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. , 2003, Diabetes.

[16]  D. Cerretti,et al.  Angiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization , 2003, Laboratory Investigation.

[17]  A. Bernstein,et al.  Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Wieting,et al.  Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins , 2003, Journal of Cell Science.

[19]  N. Hattori,et al.  Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  I. Jo,et al.  Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovine retinal pericytes. , 2003, Microvascular research.

[21]  M. Matsumura,et al.  Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. , 2003, Investigative ophthalmology & visual science.

[22]  R. Dermietzel,et al.  Angiogenesis of the blood‐brain barrier in vitro and the function of cerebral pericytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Timothy S Kern,et al.  Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.

[24]  M. Boulton,et al.  The pathogenesis of diabetic retinopathy: old concepts and new questions , 2002, Eye.

[25]  M. Skobe,et al.  Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. , 2002, The American journal of pathology.

[26]  Bernd Kirchhof,et al.  Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  T. Kern,et al.  Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. , 2001, Diabetes.

[28]  D. Voskas,et al.  Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function , 2001, EMBO reports.

[29]  J. Pfeilschifter,et al.  Expressional Regulation of Angiopoietin-1 and -2 and the Tie-1 and -2 Receptor Tyrosine Kinases during Cutaneous Wound Healing: A Comparative Study of Normal and Impaired Repair , 2001, Laboratory Investigation.

[30]  K. Alitalo,et al.  Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. , 2001, Cardiovascular research.

[31]  J. Gamble,et al.  Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions , 2000, Circulation research.

[32]  P. Campochiaro,et al.  Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization , 2000, Journal of cellular physiology.

[33]  R Pasqualini,et al.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. , 2000, Cancer research.

[34]  J. Kim,et al.  Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. , 2000, Circulation research.

[35]  D. Albert,et al.  Principles and practice of ophthalmology , 1999 .

[36]  K. Alitalo,et al.  Identification of Tek/Tie2 Binding Partners , 1999, The Journal of Biological Chemistry.

[37]  T. Quertermous,et al.  Octamer-dependent in Vivo Expression of the Endothelial Cell-specific TIE2 Gene* , 1999, The Journal of Biological Chemistry.

[38]  H. Yamane,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Inflammatory Cytokines and Vascular Endothelial Growth Factor Stimulate the Release of Soluble Tie Receptor From Human Endothelial Cells Via Metalloprotease Activation , 1999 .

[39]  T. Gardiner,et al.  Endothelium-derived agents in Pericyte function/dysfunction , 1999, Progress in Retinal and Eye Research.

[40]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[41]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[42]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[43]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[44]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[45]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.

[46]  H. Inomata,et al.  Pericytes of newly formed vessels in experimental subretinal neovascularization. , 1995, Archives of ophthalmology.

[47]  M. Shimamura,et al.  Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides. , 1991, Journal of biochemistry.

[48]  R. Ashmun,et al.  Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells , 1990 .

[49]  J. Engberg,et al.  Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA , 1988, FEBS letters.

[50]  A. Farrow.  Proliferative diabetic retinopathy: a case study. , 1988, The Journal of audiovisual media in medicine.

[51]  J. Ritz,et al.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells. , 1981, The Journal of clinical investigation.